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Low pHJaagsiekte sheep retrovirus (JSRV) and enzootic nasal tumor virus (ENTV) are two closely related oncogenic
retroviruses that share the same cellular receptor yet exhibit distinct fusogenicity and infectivity. Here, we
ﬁnd that the low fusogenicity of ENTV envelope protein (Env) is not because of receptor binding, but lies
in its intrinsic insensitivity to receptor-mediated triggering for fusion at low pH. Distinct from JSRV, shedding
of ENTV surface (SU) subunit into culture medium was not enhanced by a soluble form of receptor, Hyal2
(sHyal2), and sHyal2 was unable to effectively inactivate the ENTV pseudovirions. Remarkably, replacing ei-
ther of the two amino acid residues, N191 or S195, located in the ENTV SU with the corresponding JSRV res-
idues, H191 or G195, markedly increased the Env-mediated membrane fusion activity and infection.
Reciprocal amino acid substitutions also partly switched the sensitivities of ENTV and JSRV pseudovirions
to sHyal2-mediated SU shedding and inactivation. While N191 is responsible for an extra N-linked glycosyl-
ation of ENTV SU relative to that of JSRV, S195 possibly forms a hydrogen bond with a surrounding amino acid
residue. Molecular modeling of the pre-fusion structure of JSRV Env predicts that the segment of SU that con-
tains H191 to G195 contacts the fusion peptide and suggests that the H191N and G195S changes seen in
ENTV may stabilize its pre-fusion structure against receptor priming and therefore modulate fusion activa-
tion by Hyal2. In summary, our study reveals critical determinants in the SU subunits of JSRV and ENTV
Env proteins that likely regulate their local structures and thereby differential receptor-mediated fusion ac-
tivation at low pH, and these ﬁndings explain, at least in part, their distinct viral infectivity.icrobiology and Immunology,
umbia, MO 65211-7310, USA.
and Women's Hospital and
rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Enveloped viruses encode surface glycoproteins that recognize cellu-
lar receptors andmediate viral fusion and entry into the host cells (Cosset
and Lavillette, 2011). For many class I fusion proteins such as retrovirus
envelope (Env), receptor binding and membrane fusion are executed
by two associated subunits that are generated from proteolytic cleavage
of a precursor by host proteases (White et al., 2008). The retrovirus
Env glycoproteins consist of a surface (SU) and a transmembrane (TM)
subunit; SU is responsible for receptor binding, and TM mediates virus-
cell membrane fusion (Cofﬁn et al., 1997). At the prefusion state, the SU
subunit acts as a clamp to restrict refolding of TM and thereby prevents
premature fusion activation (Colman and Lawrence, 2003; Eckert and
Kim, 2001). Upon receptor binding, a conformational change occurs inthe SU subunit that results in the disruption of the disulﬁde bond
or non-covalent interactions between SU and TM; this causes the
constraints of SU on TM to be released, leading to the formation of a
six-helix bundle (6HB) in TM and therefore membrane fusion (Eckert
and Kim, 2001; Li et al., 2008;Melikyan, 2008; Pinter et al., 1997;Wallin
et al., 2004, 2006). There is also strong evidence that the retroviral SU
not only prevents the refolding of TMbut can also send an indispensible
signal to the TM subunit, since deletion of the receptor-binding domain
(RBD) of SU results in fusion-deﬁcient Env proteins, and soluble SU pro-
teins containing RBD are sufﬁcient to rescue their fusogenicities in trans
(Barnett and Cunningham, 2001; Lavillette et al., 2001).
While retroviruses are traditionally believed to fuse with host cells
at the plasma membrane (McClure et al., 1990), several retroviruses
have been found to require a low pH for fusion and cell entry. These in-
clude ecotropic murine leukemia virus (E-MLV) (McClure et al., 1990;
Nussbaum et al., 1993), avian sarcoma and leukosis virus (ASLV) sub-
groups A and B (Diaz-Griffero et al., 2002; Mothes et al., 2000), mouse
mammary tumor virus (MMTV) (Redmond et al., 1984; Ross et al.,
2002), equine infectious anemia virus (EIAV) (Brindley and Maury,
2005; Jin et al., 2005), foamy virus (Picard-Maureau et al., 2003), as
well as the oncogenic sheep retroviruses, jaagsiekte sheep retrovirus
Table 1
Titers of MoMLV pseudovirions bearing JSRV Env, ENTV Env or their SU mutants (AP+
foci per ml).
Env HTX HTX/LH2SN
ENTV SU WT 14±8 (2.8±1.1)×105
R177G 31±4 (7.7±0.1)×104
T180A 37±3.4 (1.8±0.2)×104
T180S 31±3.0 (1.9±0.8)×105
N191H (1.0±0.2)×103 (1.0±0.2)×105
S195G (2.0±0.3)×103 (2.4±1.7)×106
N191H/S195G (2.3±0.4)×103 (2.7±0.6)×106
JSRV SU WT (3.9±0.1)×104 (3.3±1.0)×106
G177R (7.1±0.7)×104 (6.6±2.1)×106
S180A (2.2±0.5)×104 (2.4±0.2)×106
S180T (2.3±0.2)×104 (1.4±1.8)×106
H191N (1.7±0.5)×104 (5.3±2.2)×106
G195S (2.4±1.3)×103 (5.6±0.5)×104
H191N/G195S (1.5±0.5)×102 (7.2±1.1)×104
293/GP-LAPSN cells expressing the MLV Gag-Pol proteins and AP were transfected with
plasmid DNA encoding individual Envs. Virions were harvested 48–72 h post-
transfection, and used to infect HTX and HTX cells overexpressing Hyal2 (HTX/LH2SN).
Titers were determined by counting AP+ foci 72 h post-infection. Results are averages±
standard deviations (SD) of three independent experiments. WT: wildtype. Mutants at
positions 191 and 195 and their titers are in bold.
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(Bertrand et al., 2008; Côté et al., 2008a, 2008b). Among these, the eco-
tropic Moloney MLV (MoMLV) appears to require low pH-dependent
cellular proteases for fusion activation (Kumar et al., 2007), a novel
mechanism that has been recently shown to be used by several other vi-
ruses for entry (Brindley et al., 2007; Chandran et al., 2005; Huang et al.,
2006; Pager andDutch, 2005; Pager et al., 2006; Schornberg et al., 2006;
Simmons et al., 2005). Notably, ASLV (Mothes et al., 2000), JSRV (Côté et
al., 2009), and likely MMTV as well (Wang et al., 2008), utilize an un-
usual two-step mechanism, where both receptor binding and low pH
are required for fusion and cell entry.
JSRV and ENTV are simple betaretroviruses that induce contagious
pulmonary and nasal adenocarcinoma in sheep and goats (Fan, 2003).
The Env proteins of JSRV and ENTV are active oncogenes that elicit cell
transformation in vitro and induce tumor formation in animals (Allen
et al., 2002; Caporale et al., 2006; Liu and Miller, 2007; Maeda et al.,
2001; Rai et al., 2001; Wootton et al., 2005, 2006). While the mecha-
nism underlying the tissue-speciﬁc oncogenesis by JSRV and ENTV is
still currently unknown, it is likely associated with their preferential
LTR promoter activities in the lung and nasal tissues (Dakessian and
Fan, 2008; McGee-Estrada and Fan, 2006, 2007; Palmarini et al.,
2000a). Interestingly, despite their high sequence identities at the
amino acid level in the SU subunit and that both viruses use the same
cellular receptor, hyaluronidase2 (Hyal2), for entry, the infectivity and
host ranges of JSRV and ENTV are remarkably different (Cousens et al.,
1999; Dirks et al., 2002; Rai et al., 2000, 2001). JSRV Env-pseudotyped
MLV vectors transduce a wide range of cell lines, including most
human, monkey, dog, cow and rabbit cells (Rai et al., 2000), whereas
ENTV Env-based vectors only transduce certain sheep and human cell
lines with a very low efﬁciency (Dirks et al., 2002). Additionally, we re-
cently reported that ENTV Env requires an unusually low pH (bpH 4.5)
for fusion as compared to that of JSRV (bpH 6.0) (Côté et al., 2008a,
2008b), and this likely contributes to the low infection rate of ENTV be-
cause of potential degradation of viral particles in the lysosome (Côté
et al., 2008a).
To understand the mechanism of fusion activation and cell entry
by ENTV and JSRV, we previously generated several chimeras be-
tween these two Envs, and showed that the ENTV SU subunit is pri-
marily responsible for its low fusion activity whereas the TM
subunit dictates its unusual low pH threshold (Côté et al., 2008a).
Here, we aimed to further deﬁne the underlying mechanisms of the
distinct fusogenicities between ENTV and JSRV Envs, and found that
the relatively low fusion activity of ENTV SU is not because of poor re-
ceptor binding, but lies in its intrinsic insensitivity to receptor-medi-
ated triggering. Our data support the notion that, while ENTV likely
utilizes a similar two-step mechanism as that of JSRV for fusion and
entry, there are differences in the SU subunits of these two Envs
that critically regulate their distinct fusion activation.
Results
Identiﬁcation of residues in the SU subunits of ENTV and JSRV Envs that
determine their distinct entry efﬁciencies
JSRV and ENTV share the same cellular receptor, Hyal2, for entry,
yet the titer of ENTV Env pseudovirions in most mammalian cells,
such as HTX that express an endogenous level of Hyal2, is extremely
low as compared to that of JSRV (Table 1) (Dirks et al., 2002). Re-
markably, overexpression of Hyal2 in the target cells or the replace-
ment of ENTV SU with that of JSRV dramatically rescues the ENTV
titer (Table 1) (Côté et al., 2008a; Dirks et al., 2002; Van Hoeven
and Miller, 2005), suggesting that ENTV SU and its interaction with
Hyal2 are responsible for its low entry efﬁciency. Sequence compari-
son reveals that ENTV SU is ~94% identical to JSRV SU at the amino
acid level (Cousens et al., 2004), and the region between the signal
peptide and residue 204 (Fig. 1, termed putative receptor bindingdomain (RBD)) has been previously identiﬁed to be the major deter-
minant for differential infectivity of ENTV and JSRV Env pseudotypes
(Dirks et al., 2002; Van Hoeven and Miller, 2005). The putative RBD
contains four most distinguishable changes between JSRV and ENTV,
i.e., R/G-177 (R for ENTV and G for JSRV at position 177, same nomen-
clatures for the other mutants), T/S-180, N/H-191, and S/G-195
(Fig. 1). Among these, T/S-180 is a putative N-linked glycosylation
site (N-X-S/T) common to both ENTV and JSRV, while N191 consti-
tutes an extra N-linked glycosylation site unique to ENTV.
We generated reciprocal Env mutants between ENTV and JSRV at
these four positions in the RBD, and examined their effects on viral in-
fection. The expression of these Envs and their incorporations into
MLV vectors were comparable, except that ENTV Env and its mutants
exhibited relatively higher levels of expression than those of JSRV as
determined by ﬂow cytometry and Western blot (data not shown;
also see ref. (Côté et al., 2008a)). MLV pseudotypes bearing individual
Envs were used to transduce human HTX or HTX/LH2SN cells (the lat-
ter overexpress human Hyal2), and their titers were summarized in
Table 1. While reciprocal mutations between ENTV and JSRV Envs at
position 177 and 180 did not signiﬁcantly change the viral titers in ei-
ther cell lines, substitution of ENTV S195 or N191 with the corre-
sponding JSRV G195 or H191 increased the ENTV titer by ~10 to
100-fold in HTX and HTX/LH2SN cells (Table 1). A double mutant har-
boring both S195G and N191H did not appear to further increase the
ENTV titer (Table 1). Interestingly, the reciprocal JSRV G195S mutant,
but not that of H191N, exhibited a ~10- to100-fold decreased titer in
both cell lines, and the double mutant, JSRV H191N/G195S, showed a
further drop in the infection titer (Table 1).
Taken together, these results indicated that residues at position
191 and 195 are critical for ENTV and JSRV entry, with those at posi-
tion 195 likely playing a more important role. We cannot rule out the
possibility that other residues in the SU subunit, particularly the two
additional residues in the RBD, i.e., 174 and 196, may also contribute
to the differential entry efﬁciency of JSRV and ENTV.The SU subunits of ENTV and JSRV Envs are differentially glycosylated
We next performed metabolic labeling assays and examined the
expression, processing, and possible glycosylations of these JSRV
and ENTV Env proteins and their SU mutants. As shown in Fig. 2, all
the JSRV and ENTV Env constructs were expressed and processed
with similar efﬁciencies, as evidenced by comparable band intensities
for the precursors (labeled as “FL”) and processed TMs (Fig. 2A).
Fig. 1. Sequence alignment of JSRV and ENTV SU. JSRV-7 (GenBank accession number AF357971) and ENTV-1 (Y16627 and AF401741) are two representative strains of JSRV and
ENTV. The alignment was performed using Clustal W (asterisk, invariant; colon, highly similar; dot, similar). The positions of signal peptide (SP), putative receptor-binding domain
(RBD), and transmembrane (TM) subunit are according to (Dirks et al., 2002). Four reciprocal mutation sites in the RBD between JSRV and ENTV are indicated.
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JSRV H191N) and 180 (i.e, ENTV T180A and JSRV S180A), where their
putative N-linked glyscosylation sites were disrupted or gained, exhib-
ited altered electrophoretic mobilities distinct from their respective
wildtypes (Fig. 2A). As would be expected, point mutations at the
same position 180 that retain the potential N-linked glycosylation
sites, i.e., ENTV T180S and JSRV S180T, displayed electrophoretic pat-
terns similar to their wildtypes (Fig. 2A). Together, these results indicat-
ed that the position 180 is indeed a N-linked glycosylation site common
to both ENTV and JSRV. Similar results were also obtained for shed SU
harvested from the culture media, although ENTV Env and its mutants
exhibited generally stronger signals as compared to those of JSRV and
mutants (Fig. 2C).
We then treated the Env-containing cell lysates with PNGase F, and
observed that all the ENTV and JSRVEnv constructs exhibited greatly re-
duced but similar size of FL, SU, and TM on the gel, with roughly the
same molecular weights (Fig. 2B). The decreased band intensity for
the PNGase F-treated samples shown in Fig. 2B likely resulted from
the deglycosylation thatmade the protein bands look sharper. Together,
these metabolic labeling data support the notion that both ENTV and
JSRV Envs are extensively glycosylated in the SU subunits (there is atotal of 6 and 7 potential N-linked glycosylation sites in the JSRV and
ENTV SUs, respectively), and the distinct gel mobilities observed be-
tween ENTV and JSRV SU are due to their differential N-linked glycosyl-
ations at position 191.
Two residues in the SU subunits of ENTV and JSRV Envs distinguish their
fusogenicities
The viral infection assay we employed to obtain the titers shown in
Table 1 was based on the JSRV and ENTV pseudotypes; therefore, their
titer differences should reﬂect the effect of SU changes on virus entry in-
cluding membrane fusion. We thus assessed the fusion activities of
ENTV and JSRV SU mutants using the syncytia induction and cell–cell
fusion assays we developed previously (Côté et al., 2008b). While the
wildtype ENTV Env induced small and fewer syncytia at pH 5.0 follow-
ing a prolonged 5-min pulse or a pH 4.5 treatment for 1 min as we had
shown previously, the N191H and S195G mutants produced relatively
larger (2-fold) and more syncytia (~2–3 times) under the same condi-
tions (pictures not shown). Quantitatively, the cell–cell fusion activities
of these twomutants were signiﬁcantly higher than that of ENTV wild-
type (pb0.05), although this was only evident at pH 4.0 (Fig. 3), a
Fig. 2. Env expression, processing, and SU secretion of JSRV and ENTV SU mutants.
293T cells were transfected with plasmid DNA encoding individual Envs; 48 h post-
transfection, cells were metabolically labeled for 1 h and chased for 6 h. Env proteins
in cell lysates (A and B) or culture media (C) were immunoprecipitated using anti-
FLAG beads; the resulting immunoprecipitates were left untreated (A) or treated
with PNGase F (B) overnight, and analyzed by SDS-PAGE and autoradiography. WT:
wildtype; None: untransfected control; FL: full-length Env precursor. * indicates non-
speciﬁc cellular proteins that were pulled down by anti-FLAG beads. Representative
images from three independent experiments are shown.
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membrane fusion in the cell-based assay (Côté et al., 2008a). Interest-
ingly, the JSRV G195Smutant, but not that of H191N, exhibited a signif-
icantly reduced cell–cell fusion activity (pb0.01) at all the acidic pH
tested (Fig. 3). Kinetics studies revealed that the fusion activation of
JSRV G195S mutant was also much slower than that of JSRV wildtype
and other mutants (data not shown). We noticed that, although both
ENTV N191H and S195G mutants exhibited increased fusogenicity,
they still required an extremely low pH (bpH 4.5) for fusion activation
as that of ENTVwildtype (Fig. 3, data not shown), supporting our previ-
ous conclusion that the TM subunit, rather than that of SU, determines
the unusually low pH threshold of ENTV Env for fusion (Côté et al.,
2008a). Overall, the cell fusion data demonstrate that residues at posi-
tion 191 and 195 in the ENTV and JSRV SU critically modulate their
fusogenicities.ENTV SU binds to Hyal2 as efﬁciently as does the JSRV SU
The observed effects of reciprocal SU mutants on membrane fu-
sion and infection of JSRV and ENTV could be simply explained by
their differences in binding to the Hyal2 receptor. To explore this pos-
sibility, we created soluble SU-human IgG Fc fusion proteins for some
of the key JSRV and ENTV SU mutants, and performed a series of in
vitro binding assays. We ﬁrst examined the size and glycosylation
patterns of the puriﬁed fusion proteins using SDS-PAGE in combina-
tion with SYPRO staining and Western blot. The electrophoretic mo-
bilities of these fusion proteins on the gel were generally consistent
with those seen in cell lysates and culture media shown in Fig. 2,
with the reciprocal N191H and H191N mutants exhibiting altered
mobilities (Fig. 4A). PNGase F treatment rendered all the ENTV and
JSRV SU fusion proteins to roughly the same size on the gel(Fig. 4A), again suggesting that ENTV SU has a unique N-linked glycan
at the position 191 relative to the JSRV SU.
We next performed ELISA using puriﬁed SU fusion proteins and
soluble Hyal2 (sHyal2) that we recently generated from Drosophila
S2 cells (Côté et al., 2009). We found that, quite unexpectedly, the
binding activities of wildtype ENTV and JSRV SU to sHyal2 were
very similar at all the different concentrations of SU fusion proteins
or sHyal2 being tested (Fig. 4B, data not shown). Consistently, all
the ENTV and JSRV SU mutants also exhibited comparable binding ac-
tivities to sHyal2, with levels similar to their wildtypes (data not
shown).
To rule out the possibility that the ELISA results may not reﬂect the
SU-Hyal2 interactions in cultured cells, we performed in vitro SU
binding assays using HTX and HTX/LH2SN cells expressing different
levels of Hyal2. Again, we observed similar ﬂuorescence intensities
for the ENTV and JSRV wildtypes in both cell lines (Fig. 4C), with dif-
ferent amounts of fusion proteins being tested (data not shown). The
ENTV and JSRV SU fusion protein mutants also exhibited comparable
binding activities to Hyal2 in HTX and HTX/LH2SN cells, although
slight decreases were noted for some of the ENTV mutants (Fig. 4D).
We further carried out virion-cell binding experiments using Gag-
YFP-expressing MLV pseudotypes bearing individual Envs, and
obtained similar binding proﬁles for all the Env constructs in both
HTX and HTX/LH2SN cells (data not shown). Taken together, our
data suggest that ENTV and JSRV Envs have similar binding activities
to Hyal2, at least in the cell lines we tested, and that the relatively low
fusogenicity and infectivity of ENTV cannot be explained by receptor
binding. These results are in line with a previous report by Van Hoe-
ven and Miller, which showed similar binding efﬁciencies of ENTV
and JSRV SU fusion proteins to several cell lines engineered to overex-
press human Hyal2 (Van Hoeven and Miller, 2005).
Unlike JSRV SU, shedding of ENTV SU is not enhanced by soluble Hyal2
Shedding or displacement of the receptor binding subunit of retro-
viral Env or SU upon receptor binding has been shown to be an im-
portant, though not necessary, indicator of retrovirus Env-mediated
fusion and infection (Eckert and Kim, 2001; Thali et al., 1992; Wallin
et al., 2005). Recent data from our group also demonstrated that
shedding of JSRV SU into culture media is enhanced by sHyal2, sup-
porting the conclusion that Hyal2 plays a priming role in the pH-de-
pendent, Env-mediated fusion (Côté et al., 2009). Here, we wished
to examine if shedding of ENTV SU could also be enhanced by
sHyal2 and whether or not the SU mutations could have any effect
on the SU shedding. We metabolically labeled the ENTV and JSRV
Env-expressing 293T cells in the presence of varying amounts of
sHyal2, and the shed SU proteins were immunoprecipitated from cul-
ture media and analyzed by autoradiography. Shedding of JSRV SU
was enhanced by sHyal2 in a dose-dependent manner, similar to
what we had shown previously (Côté et al., 2009); however, no en-
hanced SU shedding could be observed for ENTV Env, even with the
highest amount of sHyal2 used (Fig. 5A). Remarkably, we found that
the JSRV G195S mutant reproducibly failed to show an enhanced SU
shedding following the sHyal2 treatment, and this was in sharp con-
trast to the wildtype JSRV and other JSRV SU mutants (Fig. 5B). We
were unable to detect an enhanced SU shedding for any of the ENTV
SU mutants, including the reciprocal S195G mutant (Fig. 5C) and
the N191H/S195G double mutant (data not shown).
Despite the lack of enhancement by sHyal2, we constantly ob-
served higher basal levels of SU shedding for ENTV Env and its mu-
tants relative to that of JSRV constructs (Figs. 2 and 5A and C). To
determine if the SU or TM subunit of Env is responsible for differential
basal level of SU shedding between JSRV and ENTV, we performed
metabolical labeling assay using two chimeric Envs in which the SU
and TM subunits of JSRV and ENTV are reciprocally swapped (Côté
et al., 2008a). We observed that JE, which harbors the JSRV SU and
Fig. 3. Cell–cell fusion activities of JSRV and ENTV SU mutants. Effector cells (293 T/GFP) transfected with plasmid DNA encoding various Envs were incubated with target cells
(HTX/LH2SN) for 1 h, followed by treatment with indicated pH buffers for 1 min (JSRV) or 5 min (ENTV). Cells were then incubated in fresh growth media for 1 h at 37 °C, trypsi-
nized, and analyzed by ﬂow cytometry. (A) Dot plots from one representative experiment are presented; the percentages of fused cells were indicated in the upper-right quadrant
of the cytometry proﬁles. Note that all the JSRV constructs were treated with pH 5.0 for 1 min, and all the ENTV constructs were with pH 4.0 for 5 min. (B) Relative cell–cell fusion
activities. The relative fusion activities of JSRV and ENTV SUmutants were obtained by comparing with their own wildtype JSRV at pH 5.0 (set as 100%, left) or ENTV at pH 4.0 (set as
100%, right). The paired student's t test was used for statistical analysis; * indicates pb0.05, and ** indicates pb0.01.
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of ENTV, and that the SU shedding was further enhanced by sHyal2
resembling that of JSRV Env (Fig. 5D). In contrast, EJ which contains
the ENTV SU but JSRV TM, failed to show any detectable SU shedding
in the absence or presence of sHyal2 (Fig. 5D). These results further
support the notion that ENTV SU is indeed inherently less sensitive
to sHyal2-mediated SU triggering for shedding compared to that of
JSRV, and that the relatively higher basal levels of ENTV SU shedding
is largely controlled by the TM subunit.
ENTV Env pseudovirions are not readily inactivated by soluble Hyal2, the
effect of which can be overcome by amino acid substitutions in the SU
It is generally believed that viral fusion proteins undergoing dra-
matic conformational refolding following fusion triggering are locked
into a stable post-fusion conformation (White et al., 2008). Therefore,
virions that are prematurely subjected to these triggers are often,
though not always, inactivated in the absence of the host target mem-
brane (White et al., 2008). We recently showed that the infectivity of
JSRV Env pseudovirions is not inactivated by low pH but can beseverely impaired by sHyal2, supporting the idea that Hyal2 is direct-
ly involved in the pH-dependent membrane fusion activation of JSRV
Env (Côté et al., 2008b, 2009). Here, we tested if sHyal2 could also in-
activate the infectivity of ENTV Env pseudovirions and some of the
ENTV and JSRV mutants. We incubated the ENTV and JSRV Env pseu-
dovirions with different amounts of sHyal2 either before or after virus
binding to the target HTX/LH2SN cells, and this would allow us to dis-
tinguish the effect of sHyal2 on virus binding at the surface of the tar-
get cells and the inactivation of Env. As shown previously (Côté et al.,
2009), sHyal2 potently inhibited the infection of JSRV pseudovirions
in both the pre-binding (Fig. 6A) and post-binding (Fig. 6B) assays,
with the half-maximal inhibition concentrations of ~1 μg and
~1.5 μg per ml, respectively. In contrast, the infectivity of ENTV pseu-
dovirions, despite being inhibited, was not effectively inactivated by
sHyal2 in the pre-binding assay (reﬂecting both receptor binding
and fusion), especially at low concentrations of sHyal2 (with half-
maximal inhibition concentration of ~7 μg/ml, Fig. 6A). This was
even more apparent in the post-binding assay, where marked differ-
ences between ENTV and JSRV were noted at all the various doses of
sHyal2 being tested (Fig. 6B). Altogether, these results demonstrate
Fig. 4. JSRV and ENTV Envs exhibit similar binding activities to Hyal2. (A) Examination of puriﬁed SU fusion proteins. JSRV SU, ENTV SU, and their SU mutants fused with human IgG
Fc were expressed in 293T cells, and puriﬁed using protein A beads. Puriﬁed proteins were left untreated (upper panel), or treated with PNGase F (lower panel), and analyzed by
SDS-PAGE and Sypro Ruby staining. (B) SU-sHyal2 binding measured by ELISA. Soluble Hyal2 was coated onto ELISA plates, incubated with indicated amounts of puriﬁed JSRV SU or
ENTV SU fusion proteins, and the binding was measured using anti-human IgG coupled to HRP and ABTS substrate. Relative binding percentages were calculated by setting the
values at 3000 ng JSRV SU fusion protein as 100%. (C and D) SU-cell binding measured by ﬂow cytometry. JSRV and ENTV SU fusion protein (10 μg each) were incubated with
HTX or HTX/LH2SN cells for 3 h at 4 °C, and bound proteins were detected using anti-human IgG coupled to FITC and ﬂow cytometry. To ensure that the binding of JSRV and
ENTV SU to Hyal2 (panel B and C) is speciﬁc, we included equivalent amounts of XMRV SU-human IgG Fc fusion protein (Zheng, Y.-M. and Liu, S.-L., unpublished) in the HTX
and HTX/LL2SN cell-binding assay, and obtained similar binding intensity (HTX cells express a functional XPR1 receptor for XMRV). Panel C shows the representative histograms
for binding in HTX and HTX/LH2SN cells, and panel D represents the averages±SD of three independent binding experiments in HTX and HTX/LH2SN cells. “Sec. alone”: secondary
antibody alone.
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the sHyal2-mediated inactivation, which is in line with the above ob-
servation that sHyal2 was unable to induce enhanced ENTV SU shed-
ding as it did on the JSRV SU (Fig. 5A).
We next performed similar post-binding assays for some of the JSRV
and ENTV SU mutants, and these results are summarized in Figs. 6C and
D. We observed that, although the infectivity of the JSRV H191N mutantwas inhibited by 10 μg sHyal2 (~3-fold), itwas less sensitive to treatment
by lower concentrations of sHyal2, such as 0.5 and 1.5 μg (Fig. 6C). Strik-
ingly, we found that the infectivity of the JSRV G195S mutant was barely
inhibited by sHyal2 at all the different amounts of sHyal2 being tested
(for 1.5 μg sHayl2) (Fig. 6C). In contrast, the infectivities of two ENTV
SU mutants, N191H and S195G, were reproducibly inhibited in a dose-
dependent manner (pb0.05 or 0.01, Fig. 6D). Collectively, these results
Fig. 5. sHyal2 does not enhance the ENTV SU shedding as it does to the JSRV SU. 293T
cells transfected with plasmid DNA encoding JSRV Env, ENTV Env or their SU mutants
were metabolically labeled for 1 h and chased for 3 h. Indicated amounts of sHyal2
were then added to the media, and cells were incubated for 3 additional hours at
37 °C. Immunoprecipitated Envs from cell lysates and media were resolved on SDS-
PAGE and subjected to autoradiography. SU shedding was quantiﬁed using Quantity
One software (Bio-Rad) and band densities were normalized to the shed SU of JSRV
(A, B and D) or ENTV (C) in the absence of sHyal2 (which were set as 1.00). Represen-
tative images from three experiments are shown. None: untransfected control. * indi-
cates nonspeciﬁc cellular proteins that were pulled down by anti-FLAG beads. EJ and JE
are two chimeric Envs between JSRV and ENTV; EJ contains ENTV SU and JSRV TM,
whereas JE contains JSRV SU and ENTV TM, see ref. (Côté et al., 2008a) for details.
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sitions of ENTV and JSRV SUs are critical for sHyal2-mediated fusion acti-
vation, with residues at 195 playing the most critical role.
Discussion
A remarkable difference between JSRV and ENTV is the extremely
poor transduction efﬁciency of ENTV Env-bearing pseudotypes as
compared to that of JSRV (Dirks et al., 2002). A simple hypothesis is
that ENTV SU has a lower binding activity to Hyal2 than that of JSRV
SU, and this would restrict its fusion activation and cell entry efﬁcien-
cy (Côté et al., 2008a; Dirks et al., 2002; Van Hoeven and Miller,
2005). However, we ﬁnd here that ENTV SU binds to Hyal2 as efﬁ-
ciently as does the JSRV SU, and that the low fusogenicity of ENTV
Env is associated with its intrinsic insensitivity to Hyal2-mediated
triggering. We provided evidence that two amino acid residues in
the SU subunits of ENTV and JSRV Envs are critical for their distinct fu-
sion activation and cell entry efﬁciency.
Hyal2 plays an essential role in the pH-dependent fusion activation
of JSRV and ENTV Env proteins (Côté et al., 2008a, 2008b, 2009). We
propose that Hyal2 may initiate a conformational change of SU and
thus causes SU disassociation from TM; subsequently the TM subunit
undergoes dramatic conformational rearrangements upon low pH trig-
gering, resulting in the formation of 6HB and therebymembrane fusion
(Côté et al., 2009). Consistentwith thismodel,we showedhere and pre-
viously that shedding of JSRV SU is enhanced by sHyal2 (Côté et al.,
2009). However, here we have been repeatedly unable to detect an en-
hanced SU shedding for ENTV, even with the largest amounts of sHyal2
being tested (Figs. 5A, C and D). We observed higher basal levels of SU
shedding for ENTV Env (Figs. 2 and 5), which correlates with its higher
level of Env expression relative to that of JSRV (Fig. 5; also ref. (Côté
et al., 2008a)) and appeared to be dictated by the TM subunit
(Fig. 5D). While we cannot rule out the possibility that the association
of ENTV SU and TM may be weaker than that of JSRV in the native,
pre-fusion state, or/and that a coreceptor may be involved in the
ENTV Env-mediated entry (including fusion trigger responsible for the
basal level of SU shedding) as previously proposed by Dusty Miller
and colleagues (Van Hoeven andMiller, 2005), we favor the hypothesis
that the local structure of ENTV SU is different from that of JSRV and this
likely render the ENTV SU intrinsically less sensitive to Hyal2-mediated
triggering for fusion activation. In addition to the SU shedding data, this
hypothesis is further supported by the observation that sHyal2 does not
efﬁciently inactivate the ENTV Env pseudovirions, the effect of which is
otherwise rescued by amino acid substitutions in the ENTV SUwith that
of JSRV (Fig. 6).
We identiﬁed residues in the position 191 and 195 of ENTV and JSRV
SU to be critical for their differential membrane fusion activation by
Hyal2. Both N191 and S195 are absolutely conserved among all the
ENTV (also referred to as ENTV-1 in sheep) strains published to date, in-
cluding the recently reported 10 ENTV isolates from North America
(Walsh et al., 2010). Interestingly, the only ENTV sequence that was
cloned from a goat (referred to ENTV-2) (Ortin et al., 2003) and almost
all the endogenous sheep retroviruses (known as enJSRV) reported
(Arnaud et al., 2007; Palmarini et al., 2000b) harbor the H191 and
G195 residues, which are typical of JSRV. While the fusion property of
ENTV-2 has yet to be determined, MLV pseudotypes bearing the enJSRV
Envs exhibit a host range similar to that of JSRV (our unpublished data),
further supporting the notion that these two residues play a critical role
in the distinct fusion activation and cell entry of sheep betaretroviruses.
However, it is somewhat puzzling as to howENTV (i.e., ENTV-1)with an
intrinsically low fusogenicity spreads in sheep and causes nasal adeno-
carcinomas in vivo. Perhaps, the nasal epithelial cells of sheep express
high levels of Hyal2 receptor, which may compensate for the low fuso-
genicity of ENTV and therefore facilitate the viral spread — a situation
analogous to the Hyal2 overexpression in the cultured cells (Table 1).
This hypothesismay also explainwhy ENTV infection in sheep is strictly
Fig. 6. ENTV Env pseudovirions are not effectively inactivated by sHyal2, the effect of which can be otherwise rescued by amino acid substitutions in the SU by those of JSRV. (A) Pre-
binding assay. MLV pseudotypes bearing JSRV or ENTV Env were incubated with indicated amounts of sHyal2 for 30 min at 4 °C prior to infection of HTX/LH2SN cells. (B–D) Post-
binding assay. MLV pseudotypes bearing JSRV Env, ENTV Env, or SU mutants were bound to HTX/LH2SN cells at 4 °C for 1 h; unbound virus was removed by washing, and cells were
then incubated with indicated amounts of sHyal2. In both cases, the titers were determined by AP staining 72 h post-infection. Relative infection was calculated by setting the titers
in the absence of soluble Hyal2 as 100%. Paired student t test was used for statistical analysis; * indicates pb0.05; ** denotes pb0.01.
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infections in lymph nodes and peripheral blood mononuclear cells,
which are often observed for JSRV in sheep and ENTV-2 in goats
(Ortin et al., 2003; Palmarini et al., 1996).
The most critical residues that we identiﬁed to determine the dis-
tinct patterns of Hyal2-mediated fusion activation and cell entry be-
tween ENTV and JSRV are located at the position 195 of SU. We
showed that replacement of ENTV S195 with JSRV G195 substantially
increased the ENTV Env-mediated fusion activity at low pH (Fig. 3),
enhanced its pseudotype transduction (Table 1), and also rendered
the ENTV Env pseudovirions more sensitive to sHyal2-mediated inac-
tivation (Fig. 6). Opposite effects were also observed for the reciprocal
G195S mutant of JSRV (Table 1, Figs. 3 and 6). One possibility is that
S195 may form a hydrogen bond with a surrounding amino acid res-
idue, and this could make the ENTV SU less ﬂexible and therefore less
sensitive to Hyal2-mediated triggering as compared to that of JSRV. In
this case, position 195 is likely located in the interaction interface be-
tween Hyal2 and SU and therefore modulates the conformational
changes of SU upon receptor binding. Alternatively, position 195
may sit within the SU-TM interface and could be involved in relieving
the restraints of SU on the TM upon Hyal2 triggering.
Since both possibilities relate to the position of residues 191 and
195 within the pre-fusion conformation of the JSRV and ENTV Env,
we endeavored to model its pre-fusion structure. No pre-fusion struc-
tures are available for a retroviral SU but a pre-fusion structure
was resolved for the Ebola virus glycoprotein GP (Lee et al., 2008).
Ebola GP2 has been shown to be a member of the cl02885: Ebola_
HIV-1-like_HR1-HR2 superfamily of viral glycoproteins that includes
those of JSRV, HIV-1, the simian and feline immunodeﬁciency viruses,
and many human endogenous retroviruses (Marchler-Bauer et al.,
2011). The receptor binding domain of Ebola GP1 (Dube et al.,
2009) and the fusion peptide and heptad repeats of GP2 (for reviewsee (Dutch et al., 2000)) have been identiﬁed. We aligned the JSRV re-
ceptor binding domain with that of Ebola GP1 and the JSRV TM with
that of Ebola GP2 and submitted the alignment to SwissModel molec-
ular modeling program (Arnold et al., 2006; Guex and Peitsch, 1997).
Fig. 7 shows a portion of the molecular surface of the JSRV Env model
that includes the segment containing residues 191 and 195. Surpris-
ingly, these two residues are predicted to fold adjacent to (H191)
and just beneath (G195) the fusion peptide in TM, favoring the alter-
native possibility that the residues lie in the SU-TM interface in a po-
sition to inﬂuence the stability of the pre-fusion Env. The additional
hydrogen bonds provided by S195 and N191 could stabilize Env
against receptor triggering, thus requiring greater numbers of recep-
tor to be present on host cells for infection. In this regard, it is very in-
teresting to note that an HIV-1 gp120 H66Nmutant has been recently
found to locate between the receptor-binding and gp41-interactive
surface of gp120 and stabilize the HIV-1 Env complex once the CD4-
bound state is established (Kassa et al., 2009). Future work should
aim to solve the 3-D structures of JSRV and ENTV SU in order to un-
derstand the conformational changes of ENTV and JSRV SUs upon
Hyal2 binding, particularly the roles of key amino acid residues in
modulating the fusion activation processes.
Materials and methods
Cell lines and reagents
293T, 293T/GFP (293T cells stably expressing GFP), HTX (a subclone
of HT1080), 293/LH2SN (293 cells stably expressing human Hyal2),
HTX/LH2SN (HTX cells stably expressing human Hyal2), and 293/GP-
LAPSN (a packaging cell line stably expressing MoMLV Gag-Pol and
MoMLV retroviral vector encoding alkaline phosphatase) have been de-
scribed previously (Côté et al., 2008b; Miller and Chen, 1996; Rai et al.,
Fig. 7. Molecular modeling of the pre-fusion structure of JSRV Env suggests that residues
191 and 195 lie on the interface of SU and TM and modulate receptor triggering by
inﬂuencing the stability of the pre-fusion structure. A portion of the molecular surface of
thepre-fusion JSRV Envmodel renderedusing 3-DMolecule (VectorNTI) is shown. Arrows
point to the locations of residues 191 and 195 (shown in red). H191 is predicted to lie on
the surface interactingwith residues in the fusionpeptidewhileG195 is not visible because
it is predicted to lie below the surface beneath the fusion peptide. The remaining residues
in the segment 188 to 199 are shown in green. The fusion peptide is shown in yellow. All
other residues are shown in white.
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(DMEM) (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bo-
vine serum (FBS) andmaintained at 37 °C in a 10% CO2–air atmosphere
at 100% relative humidity. The ﬂuorescent dye, 5-(and-6)-(((4-chloro-
methyl) benzoyl) amino) tetramethylrhodamine (CMTMR), and Lipo-
fectamine 2000 were purchased from Invitrogen. The anti-FLAG
monoclonal antibody beads (EZview™ Red), and the secondary anti-
human IgG antibody coupled to ﬂuorescein isothiocyanate (FITC)
were purchased from Sigma (St. Louis, MO).
Constructs
The parental JSRV and ENTV Env-encoding vectors, with a FLAG
tag at both the N- and C-termini, have been previously described
(Côté et al., 2008a, 2008b). Point mutations in the SU subunits of
JSRV and ENTV Envs were introduced by overlapping PCR using the
parental JSRV and ENTV Env-encoding plasmids as templates. The pa-
rental JSRV and ENTV SU fused with human IgG Fc portion have also
been described previously (Liu et al., 2003a; Van Hoeven and Miller,
2005); the point mutations in the SU region were generated using
the Quickchange Site-directed Mutagenesis kit (Stratagene, La Jolla,
CA) with some modiﬁcations or overlapping PCR strategy (Liu et al.,
2003b). All mutants were conﬁrmed by DNA sequencing.
Metabolic labeling
Themetabolic labeling assaywas performed as described previously
(Côté et al., 2008b). Brieﬂy, 293T cells were transfected using the calci-
um phosphate method; 24 h post-transfection, cells were starved in
cysteine/methionine-free media for 30 min at 37 °C, and pulsed with
62.5 μCi 35S-cysteine/methionine for 1 h at 37 °C. The radiolabelled pro-
teins were chased for 6 h, and Env proteins in supernatants and cell ly-
sates were immunoprecipitated using anti-FLAG beads (Sigma).
Immunoprecipated proteins were either left untreated, or subjected to
treatment with 500 units PNGase F (New England BioLabs, Ipswich,MA) overnight, resolved on SDS-PAGE, and visualized using a Phosphor
Imager. Where applicable, appropriate amounts of sHyal2 were added
to the media following a 3-h chase period; cells were chased for an ad-
ditional 3 h before Env proteins in the supernatants and cell lysates
were immunoprecipitated and analyzed.
Cell-based fusion assays
The syncytium induction assay was performed as described previ-
ously (Côté et al., 2008a, 2008b). Brieﬂy, 293/LH2SN cells plated in 6-
well plates were transfected with 2 μg of plasmid DNA encoding Env
and 0.5 μg of pCMV-GFP-encoding plasmid (kindly provided by Fran-
çois-Loïc Cosset, Lyon, France) using the calcium phosphate method.
Twenty-four hours post-transfection, cells were treated with a pH
5.0 buffer (PBS-10 mM HEPES-10 mM MES) for either 1 or 5 min at
37 °C. Cells were then incubated at 37 °C in complete growth media,
and pictures were taken 1 h after the treatment using a ﬂuorescence
microscope (Carl Zeiss, Goettingen, Germany).
For the cell–cell fusion assay, 293T/GFP cells were transfected
using Lipofectamine 2000 (Invitrogen) with plasmid DNAs encoding
individual Envs. Twenty-four hours post-transfection, cells were de-
tached using PBS-0.5 mM EDTA, and co-cultured at a 2:1 ratio with
CMTMR pre-labeled effector HTX/LH2SN cells for 1 h at 37 °C. For
JSRV Env-expressing cells, cells were treated for 1 min with pH 4.5,
5.0, 5.5 or 7.0, and allowed to recover in normal growth medium for
1 h. For ENTV Env-expressing cells, wells were pre-coated with
poly-L-lysine (Sigma) (to prevent cell detachment due to the more
acidic pH treatment) and cells were co-cultured for 1 h prior to a 5-
min treatment with pH 4.0, 4.5 or 7.0. In all cases, cells were trypsi-
nized and analyzed by ﬂow cytometry using a FACSCalibur (BD Bio-
science, Mississauga, ON, Canada).
Protein puriﬁcation
The production and puriﬁcation of soluble Hyal2 (sHyal2) has
been described previously (Côté et al., 2009; Vigdorovich et al.,
2005). The JSRV and ENTV SU fusion proteins as well as their mutants
were produced by transfection of 293T cells using the calcium-
phosphate method. Twelve hours post-transfection, cells were fed
with media containing 2% ultra-low IgG FBS (Invitrogen). The fusion
proteins were puriﬁed using recombinant protein A beads (GE Health,
Uppsala, Sweden) as described previously (Liu et al., 2003a), with size
and purity determined by SDS-PAGE and Sypro Ruby staining (Bio-
Rad, Hercules, CA).
ELISA and SU binding assays
sHyal2 (0.50 μg per well) was coated on ELISA plates (Costar, Low-
ell, MA) overnight at 4 °C. Plates were blocked using 5% milk, 0.05%
Tween-20 in PBS for 1 h at room temperature and washed three
times with wash buffer (PBS, 0.05% Tween-20). Fusion proteins
were incubated for 1 h at 37 °C and unbound proteins were washed
three times. Bound fusion proteins were detected using anti-human
IgG coupled to HRP and 2, 2'-azino-bis (3-ethylbenzthiazoline-6-sul-
phonic acid (ABTS, Sigma). For SU fusion protein binding assays,
HTX cells or HTX/LH2SN cells overexpressing Hyal2 were incubated
for 3 h at 4 °C with 10 μg of puriﬁed fusion proteins. Following 3
washes with PBS plus 2% FBS, cells were stained with FITC-coupled
anti-human IgG, and analyzed by ﬂow cytometry.
Pseudovirion production, binding, and infection
The packaging 293/GP-LAPSN cell line was transfected with plas-
mids encoding individual Envs to produce alkaline phosphatase
(AP)-expressing pseudovirions. Supernatants were harvested 48 and
72 h post-transfection, and cell debris was removed by centrifugation
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cells in the presence of 5 μg/ml Polybrene (Sigma), and AP-positive
foci were counted 72 h post-infection as previously described (Côté
et al., 2008a). Pseudovirions containing MLV Gag-YFP were produced
by co-transfection of 293/GP-LAPSN cells with Env-encoding plas-
mids together with an MLV Gag-YFP encoding plasmid (kind gift of
Walther Mothes, Yale University, New Haven, CT) at a ratio of 2.5:1.
Comparable transfection efﬁciency was veriﬁed by ﬂuorescence mi-
croscopy. Virions were harvested at 48 and 72 h post-transfection,
and were puriﬁed by ultracentrifugation on 20% sucrose cushion as
described previously (Côté et al., 2008a). Equal amounts of virions
were used for binding to HTX and HTX/LH2SN cells for 3 h at 4 °C in
the presence of Polybrene. Unbound virions were washed three
times with PBS plus 2% FBS, and remaining virions bound to cells
were measured by ﬂow cytometry.
For the virus inactivation assay, virions were pre-incubated with
appropriate amounts of sHyal2 for 30 min at 4 °C and then used to in-
fect HTX/LH2SN cells in the presence of Polybrene. Alternatively,
HTX/LH2SN cells were pre-bound with appropriate amounts of viral
supernatant in the presence of Polybrene at 4 °C for 1 h. Unbound vi-
rions were removed, and indicated amounts of sHyal2 were added to
the media. AP+ foci were counted 72 h post-infection. In each inde-
pendent experiment, comparable multiplicity of infections (MOIs)
were used for infection with all viral pseudotypes.
Molecular modeling
The RBD, fusion peptide and ﬁrst heptad repeat of JSRV Env were
alignedwith the analogous domains of the Ebola Zaire GP and the align-
ment submitted for molecular modeling (SwissModel) using the pre-
fusion structure of Ebola GP (3CSY) as a template. Only a portion of
the molecular surface of the pre-fusion JSRV Env model rendered
using 3-D Molecule (Vector NTI) is shown in this study.
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